Madrigal Research Center

Orlando, Florida 32809

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Liver, Hepatic Impairment, NASH - Nonalcoholic Steatohepatitis, Renal Impairment

Studies at this site

• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function — Completed
• Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects — Completed